Neural Effects of Green Tea Extract on Dorsolateral Prefrontal Cortex
1 other identifier
interventional
12
1 country
1
Brief Summary
Green tea is being recognized as a beverage with potential benefits for human health and on cognitive function. In vitro and in vivo studies provide preliminary evidence that green tea intake may play a positive role in improving effects on cognitive functions. The investigators aim to examine the neural effects of green tea extract on brain activation in humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 5, 2012
CompletedFirst Posted
Study publicly available on registry
June 8, 2012
CompletedJune 8, 2012
June 1, 2012
6 months
June 5, 2012
June 7, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Functional magnetic resonance imaging (fMRI) in healthy volunteers while they performed a working memory task
Whole brain analysis with a cluster-level threshold was followed by an a priori defined region of interest analysis of the dorsolateral prefrontal cortex including a cluster-level threshold and family-wise error adjustment for multiple comparisons.
0 and 45 min
Study Arms (4)
Green tea extract, 250 ml
ACTIVE COMPARATORSingle intragastric instillation of 250 ml green tea extract
Green tea extract, 500 ml
ACTIVE COMPARATORIntragastric instillation of 500 ml green tea extract solution
Control solution, 250 ml
PLACEBO COMPARATORIntragastric instillation of 250 ml control solution
Control solution, 500 ml
PLACEBO COMPARATORSingle intragastric instillation of 500 ml control solution
Interventions
Intragastric instillation by feeding tube
Intragastric instillation by feeding tube
Intragastric instillation by feeding tube
Intragastric instillation by feeding tube
Eligibility Criteria
You may qualify if:
- right-handed healthy males, no drugs, non-smoking
You may not qualify if:
- drug abuse, smoker, left-handed
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
Basel, CH-4031, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christoph Beglinger, MD
University Hospital, Basel, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
June 5, 2012
First Posted
June 8, 2012
Study Start
July 1, 2010
Primary Completion
January 1, 2011
Study Completion
January 1, 2012
Last Updated
June 8, 2012
Record last verified: 2012-06